Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 126.83 billion. The enterprise value is 144.09 billion.
Market Cap | 126.83B |
Enterprise Value | 144.09B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | May 13, 2024 |
Share Statistics
Sanofi has 1.25 billion shares outstanding. The number of shares has decreased by -5.25% in one year.
Shares Outstanding | 1.25B |
Shares Change (YoY) | -5.25% |
Shares Change (QoQ) | -0.50% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 55.06% |
Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 30.11 and the forward PE ratio is 12.37. Sanofi's PEG ratio is 1.64.
PE Ratio | 30.11 |
Forward PE | 12.37 |
PS Ratio | 2.69 |
PB Ratio | 1.74 |
P/FCF Ratio | 20.35 |
PEG Ratio | 1.64 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.04, with an EV/FCF ratio of 23.13.
EV / Earnings | 34.18 |
EV / Sales | 3.06 |
EV / EBITDA | 12.04 |
EV / EBIT | 17.12 |
EV / FCF | 23.13 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 32.54.
Current Ratio | 1.00 |
Quick Ratio | 0.52 |
Debt / Equity | 32.54 |
Debt / EBITDA | 1.97 |
Debt / FCF | 3.81 |
Interest Coverage | 14.02 |
Financial Efficiency
Return on equity (ROE) is 5.81% and return on invested capital (ROIC) is 5.57%.
Return on Equity (ROE) | 5.81% |
Return on Assets (ROA) | 4.16% |
Return on Capital (ROIC) | 5.57% |
Revenue Per Employee | 546,882 |
Profits Per Employee | 48,973 |
Employee Count | 86,088 |
Asset Turnover | 0.37 |
Inventory Turnover | 1.43 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.02% in the last 52 weeks. The beta is 0.42, so Sanofi's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | +2.02% |
50-Day Moving Average | 94.94 |
200-Day Moving Average | 90.61 |
Relative Strength Index (RSI) | 72.11 |
Average Volume (20 Days) | 1,233,230 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 47.08 billion and earned 4.22 billion in profits. Earnings per share was 3.36.
Revenue | 47.08B |
Gross Profit | 32.38B |
Operating Income | 8.50B |
Pretax Income | 5.58B |
Net Income | 4.22B |
EBITDA | 11.75B |
EBIT | 8.50B |
Earnings Per Share (EPS) | 3.36 |
Balance Sheet
The company has 6.80 billion in cash and 23.75 billion in debt, giving a net cash position of -16.96 billion or -13.53 per share.
Cash & Cash Equivalents | 6.80B |
Total Debt | 23.75B |
Net Cash | -16.96B |
Net Cash Per Share | -13.53 |
Equity (Book Value) | 73.00B |
Book Value Per Share | 58.10 |
Working Capital | 54.00M |
Cash Flow
In the last 12 months, operating cash flow was 8.12 billion and capital expenditures -1.89 billion, giving a free cash flow of 6.23 billion.
Operating Cash Flow | 8.12B |
Capital Expenditures | -1.89B |
Free Cash Flow | 6.23B |
FCF Per Share | 4.97 |
Margins
Gross margin is 68.77%, with operating and profit margins of 18.04% and 8.95%.
Gross Margin | 68.77% |
Operating Margin | 18.04% |
Pretax Margin | 11.85% |
Profit Margin | 8.95% |
EBITDA Margin | 24.97% |
EBIT Margin | 18.04% |
FCF Margin | 13.23% |
Dividends & Yields
This stock pays an annual dividend of 3.76, which amounts to a dividend yield of 3.72%.
Dividend Per Share | 3.76 |
Dividend Yield | 3.72% |
Dividend Growth (YoY) | 5.62% |
Years of Dividend Growth | n/a |
Payout Ratio | 111.57% |
Buyback Yield | 5.25% |
Shareholder Yield | 8.96% |
Earnings Yield | 3.32% |
FCF Yield | 4.91% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |